治疗骨质疏松症的新药阿仑膦酸钠(alendronate sodi-um)两年前就已进入我国医药市场,国内同类产品也已相继上市。国外文献早于1996年就报道该药在治疗骨质疏松症的同时会导致食管炎;且受累病人日益增多,甚至演变成食管溃疡。秦亚丽等撰文综述了骨质疏松症的防治,曾引用以阿仑膦酸钠治疗骨质疏松症的国内文献两篇,其中一篇系报道国产该药(商品名天可)的临床应用。值得 Alendronate (alendronate sodi-um), a new drug for the treatment of osteoporosis, entered the pharmaceutical market in China two years ago and similar domestic products have also been listed one after another. Foreign literature as early as 1996 reported that the drug in the treatment of osteoporosis will lead to esophagitis; and affected patients is increasing, and even evolved into esophageal ulcer. Qin Yali and other articles reviewed the prevention and treatment of osteoporosis, had cited the alendronate treatment of osteoporosis in the domestic literature two, one of the report of the domestic drug (brand name Tian Ke) clinical application. worth it